Further evidence that leukotrienes are the major mediators of allergic constriction in human bronchi.
Björck
T
T
Department of Physiology, Karolinska Institutet, Stockholm, Sweden.
Harada
Y
Y
Dahlén
B
B
Zetterström
O
O
Johansson
G
G
Rodriguez
L
L
Hedqvist
P
P
Dahlén
S E
SE
D000485:Allergens / Q000494:pharmacology; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D001249:Asthma / Q000209:etiology / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology*; D006633:Histamine Antagonists / Q000494:pharmacology; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications; D007073:Immunoglobulin E / Q000276:immunology; D007191:Indazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D002722:Chlorobenzenes
D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D006633:Histamine Antagonists; D007073:Immunoglobulin E; D007191:Indazoles; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes; C026408:anti-IgE antibodies; C060893:MK-886; D002722:Chlorobenzenes; C054217:ICI 198615